Status:
UNKNOWN
Impact of Information About Booster Vaccination Against DTPolio at 25 Years on This Booster Vaccination's Realization
Lead Sponsor:
Université de Reims Champagne-Ardenne
Conditions:
Vaccination
Eligibility:
All Genders
25-25 years
Brief Summary
The aim of vaccination is to protect the patient against disease by stimulating his immune system. DTPolio is a tetravalent vaccine providing protection against pertussis, diphtheria, tetanus and poli...
Detailed Description
The aim of the study is to evaluate impact of information about booster vaccination against DTPolio at 25 years on this booster vaccination's realization.
Eligibility Criteria
Inclusion
- aged 25 years old in 2020
- without delivery of DTPolio vaccine in 2019 or 2020
Exclusion
- None
Key Trial Info
Start Date :
June 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
2125 Patients enrolled
Trial Details
Trial ID
NCT04869735
Start Date
June 4 2021
End Date
September 1 2022
Last Update
July 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Université de Reims Champagne-Ardenne
Reims, France